Skip to main navigation menu Skip to main content Skip to site footer

Spontaneous bilateral lower limb arterial ischemia due to mild COVID-19

Isquemia arterial bilateral espontánea de extremidades inferiores por COVID-19 leve




Section
Case Reports

How to Cite
Mera Martínez , P. F. ., Tobar Marcillo, M. A. ., Guerrero Montero, A. G. . . ., Benavides Recalde , J. ., Burbano Andrade, G. A. . ., & Portillo, J. D. (2022). Spontaneous bilateral lower limb arterial ischemia due to mild COVID-19. Journal of Medicine and Surgery Repertoire, 31, 81-86. https://doi.org/10.31260/RepertMedCir.01217372.1402

Dimensions
PlumX
Citations
license

   

Marco Adolfo Tobar Marcillo

    Gissel Alejandra Burbano Andrade

      José Dario Portillo

        Paulo Francisco Mera Martínez ,

        Residente I Cirugía General. Universidad Nacional de Colombia.


        Aida Gabriela Guerrero Montero,

        Residente de Medicina Interna. Universidad Nacional de Colombia.


        José Dario Portillo,

        Estudiante de Maestría en Ciencias Biológicas. Pontificia Universidad Javeriana.


        Introduction: COVID-19 infection causes pneumonia as part of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), ranging from asymptomatic and mild disease to a critical and severe condition mediated by a dysregulated immune response. Case presentation: 47-year-old male patient, from an urban area,  with no significant medical history. He attended a hospital´s emergency room with lower limb pain since three days prior to consultation.  Likewise, he reported previous mild respiratory symptoms.  The SARS-CoV-2 test result was positive. Lower-extremity arterial duplex ultrasound showed adequate blood flow with complete distal artery obstruction.  Discussion and conclusions: a case is reported on a patient with mild COVID-19 who developed spontaneous lower extremity arterial ischemia requiring amputation. Emphasis is placed on some theories that suggest immune thrombosis and endothelial dysfunction as the causative mechanisms of this complication.


        Article visits 515 | PDF visits 257


        Downloads

        Download data is not yet available.
        1. Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ [Internet]. 2020;368, m1091. Disponible en: 10.1136/bmj.m1091 DOI: https://doi.org/10.1136/bmj.m1091
        2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA [Internet]. 2020; Disponible en: 10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585
        3. Y. Rodríguez, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID- 19. J Autoimmun [Internet]. 114 (2020) 102506. Disponible en: https://doi.org/10.1016/j.jaut.2020.102506 DOI: https://doi.org/10.1016/j.jaut.2020.102506
        4. Wu Z, Mcgoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323:1239. DOI: https://doi.org/10.1001/jama.2020.2648
        5. Y. Zuo, S. Yalavarthi, H. Shi, K. Gockman, M. Zuo, J.A. Madison, C. Blair,, A. Weber, B.J. Barnes, M. Egeblad, R.J. Woods, Y. Kanthi, J.S. Knight. Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. MedRxiv [Internet]. 2020; Disponible en: https://doi.org/10.1101/2020.04.09.20059626 In press DOI: https://doi.org/10.1101/2020.04.09.20059626
        6. N. Sethuraman, S.S. Jeremiah, A. Ryo. Interpreting diagnostic tests for SARS-CoV- 2. J Am Med Assoc [Internet]. 323 (22) (2020) 2249-2251. Disponible en: https://doi.org/10.1001/jama. 2020.8259 In press DOI: https://doi.org/10.1001/jama.2020.8259
        7. M.Z. Tay, C.M. Poh, L. Rénia, P.A. MacAry, L.F.P. Ng. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol [Internet]. 20 (2020) 363-374. Disponible en: https://doi.org/10.1038/s41577-020-0311-8 In press. DOI: https://doi.org/10.1038/s41577-020-0311-8
        8. Q.-X. Long, B.-Z. Liu, H.-J. Deng, G.-C. Wu, K. Deng, Y.-K. Chen, P. Liao, J.-F. Qiu, Y. Lin, X.-F. Cai, D.-Q. Wang, Y. Hu, J.-H. Ren, N. Tang, Y.-Y. Xu, L.-H. Yu, Z. Mo, F. Gong, X.-L. Zhang, W.-G. Tian, L. Hu, X.-X. Zhang, J.-L. Xiang, H.-X. Du, H.-, W. Liu, C.-H. Lang, X.-H. Luo, S.-B. Wu, X.-P. Cui, Z. Zhou, M.-M. Zhu, J. Wang, C.-, J. Xue, X.-F. Li, L. Wang, Z.-J. Li, K. Wang, C.-C. Niu, Q.-J. Yang, X.-J. Tang, Y. Zhang, X.-M. Liu, J.-J. Li, D.-C. Zhang, F. Zhang, P. Liu, J. Yuan, Q. Li, J.-L. Hu, et al. Antibody responses to SARS-CoV-2 in patients with COVID- 19. Nat Med [Internet]. 2020; Disponible en: https://doi.org/10.1038/s41591-020-0897-1 In press. DOI: https://doi.org/10.1038/s41591-020-0897-1
        9. S.Q. Du, W. Yuan. Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis. J Med Virol [Internet]. 2020; Disponible en: https://doi.org/10.1002/jmv.25866 In press jmv.25866 DOI: https://doi.org/10.1002/jmv.25866
        10. Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., & Abbate, A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5), 319-329. DOI: https://doi.org/10.1038/s41577-021-00536-9
        11. Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;24;5(1):293. DOI: https://doi.org/10.1038/s41392-020-00454-7
        12. Iba, T., Levy, J. H., Levi, M., Connors, J. M. & Thachil, J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48, 1358-1364. DOI: https://doi.org/10.1097/CCM.0000000000004458
        13. Kaur P, Qaqa F, Ramahi A, Shamoon Y, Singhal M, Shamoon F, Maroules M, Singh B. Acute upper limb ischemia in a patient with COVID-19. Hematol Oncol Stem Cell Ther. 2020;13:S1658-3876(20)30096-0.
        14. Xiong M, Liang X, Wei YD. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis. Br J Haematol. 2020;189: 1050-1052. DOI: https://doi.org/10.1111/bjh.16725
        15. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost [Internet]. 2020;18: 1421-1424. Disponible en: https://doi.org/10.1111/jth.14830 DOI: https://doi.org/10.1111/jth.14830
        16. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers, DAMPJ, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:148-150. DOI: https://doi.org/10.1016/j.thromres.2020.04.041
        17. Liwinski, T., Zheng, D. & Elinav, E. The microbiome and cytosolic innate immune receptors. Immunol Rev [Internet]. 2020; Disponible en: https://doi.org/10.1111/imr.12901 DOI: https://doi.org/10.1111/imr.12901
        18. Toldo, S., Bussani, R., Nuzzi, V., Bonaventura, A., Mauro, A. G., Cannatà, A., Pillappa, R., Sinagra, G., Nana-Sinkam, P., Sime, P., & Abbate, A. Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm Res Off J Eur Histamine Res Soc. 2021;70(1), 7-10. DOI: https://doi.org/10.1007/s00011-020-01413-2
        19. Rodrigues, T. S., de Sá, K., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., Veras, F. P., Toller-Kawahisa, J. E., Nascimento, D. C., de Lima, M., Silva, C., Caetite, D. B., Martins, R. B., Castro, I. A., Pontelli, M. C., de Barros, F. C., Zamboni, D. S. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218(3), e20201707. DOI: https://doi.org/10.1084/jem.20201707
        20. Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E., Meijers, J. C., Brandjes, D. P., & van Gorp, E. Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol [Internet]. 2012;84(10), 1680-1696. Disponible en: https://doi.org/10.1002/jmv.23354 DOI: https://doi.org/10.1002/jmv.23354
        21. Godo, S. & Shimokawa, H. Endothelial functions. Arter Thromb Vasc Biol. 2017;37, 108-114. DOI: https://doi.org/10.1161/ATVBAHA.117.309813
        22. Sturtzel, C. Endothelial cells. Adv Exp Med Biol. 2017;1003, 71-91. DOI: https://doi.org/10.1007/978-3-319-57613-8_4
        23. Kruger-Genge, A., Blocki, A., Franke, R. P. & Jung, F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20, 4411. DOI: https://doi.org/10.3390/ijms20184411
        24. Escher, R., Breakey, N. & Lammle, B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190, 62. DOI: https://doi.org/10.1016/j.thromres.2020.04.014
        25. Green, S. J. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microbes Infect. 2020;22, 149-150. DOI: https://doi.org/10.1016/j.micinf.2020.05.006
        26. Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7, 803-815. DOI: https://doi.org/10.1038/nri2171
        27. Akerstrom, S. et al. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005;79, 1966-1969. DOI: https://doi.org/10.1128/JVI.79.3.1966-1969.2005
        28. Akerstrom, S., Gunalan, V., Keng, C. T., Tan, Y. J. & Mirazimi, A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology. 2009;395, 1-9. DOI: https://doi.org/10.1016/j.virol.2009.09.007
        29. Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18, 1738-1742. DOI: https://doi.org/10.1111/jth.14850
        30. Ranucci, M. et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18, 1747-1751. DOI: https://doi.org/10.1111/jth.14854
        31. Ciceri, F. et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22, 95-97. DOI: https://doi.org/10.51893/2020.2.pov2
        32. Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6);1099-1102. DOI: https://doi.org/10.1007/s00134-020-06033-2
        33. Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., Yadav, V., Wang, J., Woodard, W., Lezak, S. P., Lugogo, N. L., Smith, S. A., Morrissey, J. H., Kanthi, Y., & Knight, J. S. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med [Internet]. 2020;12(570), eabd3876. Disponible en: https://doi.org/10.1126/scitranslmed.abd3876 DOI: https://doi.org/10.1126/scitranslmed.abd3876
        Sistema OJS 3.4.0.5 - Metabiblioteca |